皮膚糸状菌症治療の世界市場レポート 2025年

皮膚糸状菌症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR（複合年間成長率）6.4％で142億米ドルに成長します。予測期間の成長は、技術革新、研究開発、人口動態の変化、規制環境、消費者の嗜好、世界の健康問題などに起因しています。予測期間における主な動向としては、継続的な研究開発、個別化医療への注力、局所療法の需要増加、新規療法の出現、自然療法へのシフトなどが挙げられます。

世界の真菌感染症の流行増加は、今後の皮膚糸状菌症治療市場の成長を牽引すると予想されます。真菌感染症は、真菌が体内や体外で過剰に増殖し、かゆみ、発赤、不快感などの症状を引き起こすことで発症します。真菌感染症の発生率の増加は、気候変動、世界化、都市化、免疫不全者の増加などの要因に起因しています。皮膚糸状菌症治療は、特定の種類の真菌によって引き起こされる皮膚、毛髪、爪に影響を及ぼす真菌感染症に対処するために使用され、症状の緩和や感染の拡大防止に役立ちます。例えば、スイスに本部を置く保健機関である世界保健機関（WHO）は2024年9月、年間650万人以上が真菌感染症に罹患し、毎年約380万人が死亡していると報告しました。これは、これらの感染症、特にアスペルギルス・フミガータスのような病原体による感染症が、重大な死亡率につながっていることを浮き彫りにしています。

皮膚糸状菌症治療市場の主要企業は、治療効果を高め、患者の満足度を向上させるために、パウダーやクリームなどの局所治療薬の開発に注力しており、進化する市場の需要に対応しています。皮膚糸状菌症用のパウダーやクリームは、かゆみを和らげ、水分を吸収し、真菌の増殖を抑制し、治癒を促進し、さらなる感染拡大を防ぐように設計されています。例えば、2022年5月、バイエルはカネステンパウダーとクリームを発売し、白癬、靴下痒み、皮膚カンジダ症、水虫、紅色陰癬、真菌性爪感染症などの様々な真菌性皮膚感染症を緩和します。この製品は、通常のタルカムパウダーの5倍の緩和効果があり、チクチクする熱、赤み、皮膚の炎症、かゆみ、真菌感染を緩和します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界皮膚糸状菌症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の皮膚糸状菌症治療市場：成長率分析
• 世界の皮膚糸状菌症治療市場の実績：規模と成長, 2019-2024
• 世界の皮膚糸状菌症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界皮膚糸状菌症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の皮膚糸状菌症治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 所定
• 店頭
• 世界の皮膚糸状菌症治療市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗感染性
• 抗真菌剤
• ステロイド
• その他の製品タイプ
• 世界の皮膚糸状菌症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• トピック
• 世界の皮膚糸状菌症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界の皮膚糸状菌症治療市場、処方薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口抗真菌薬
• 局所抗真菌薬
• 併用療法
• 世界の皮膚糸状菌症治療市場、店頭販売のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所抗真菌クリーム
• 抗真菌粉末
• 抗真菌スプレー

第7章 地域別・国別分析

• 世界の皮膚糸状菌症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の皮膚糸状菌症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 皮膚糸状菌症治療市場：競合情勢
• 皮膚糸状菌症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Ltd.
• Merck & Co. Inc.
• Mylan N.V.
• Astellas Pharma Inc.
• Valeant Pharmaceuticals International Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Fougera Pharmaceuticals Inc.
• Galderma S.A.
• Dr. Reddy's Laboratories Ltd.
• AmDerma Pharmaceuticals LLC
• LEO Pharma A/S
• Glenmark Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 皮膚糸状菌症治療市場2029：新たな機会を提供する国
• 皮膚糸状菌症治療市場2029：新たな機会を提供するセグメント
• 皮膚糸状菌症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dermatophytosis, commonly known as ringworm, is a fungal infection of the skin, hair, or nails caused by dermatophytes. It presents symptoms such as redness, itching, and ring-shaped rashes, spreading through direct contact with infected individuals or surfaces. Treatment typically involves topical antifungal medications such as clotrimazole or terbinafine, and in severe cases, oral antifungal drugs such as itraconazole or fluconazole.

The main types of dermatophytosis treatment include prescribed and over-the-counter options. Anti-infective products combat infectious organisms such as bacteria, viruses, fungi, and parasites. These products are categorized as anti-infective, antifungal, steroid, and others, administered orally or topically by end users such as hospitals and clinics.

The dermatophythosis treatment market research report is one of a series of new reports from The Business Research Company that provides dermatophythosis treatment market statistics, including dermatophythosis treatment industry global market size, regional shares, competitors with a dermatophythosis treatment market share, detailed dermatophythosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dermatophythosis treatment industry. This dermatophythosis treatment market research report delivers a complete perspective

The dermatophytosis treatment market size has grown strongly in recent years. It will grow from $10.38 billion in 2024 to $11.07 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increased awareness, advancements in diagnostic techniques, environmental factors, antifungal resistance, population growth, immune compromised population.

The dermatophytosis treatment market size is expected to see strong growth in the next few years. It will grow to $14.2 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological innovations, research and development, changing demographics, regulatory environment, consumer preferences, global health concerns. Major trends in the forecast period include continued research and development, focus on personalized medicine, rising demand for topical therapies, emergence of novel therapies, shift towards natural remedies.

The rising prevalence of fungal infections worldwide is expected to drive the growth of the dermatophytosis treatment market in the future. A fungal infection occurs when fungi grow excessively on or inside the body, causing symptoms such as itching, redness, and discomfort. The increasing incidence of fungal infections is attributed to factors such as climate change, globalization, urbanization, and a rising number of immunocompromised individuals. Dermatophytosis treatment is used to address fungal infections affecting the skin, hair, and nails caused by specific types of fungi, helping to alleviate symptoms and prevent the spread of the infection. For example, in September 2024, the World Health Organization (WHO), a health organization based in Switzerland, reported that over 6.5 million people are affected by fungal infections annually, resulting in approximately 3.8 million deaths each year. This highlights the significant mortality linked to these infections, particularly those caused by pathogens like Aspergillus fumigatus.

Leading companies in the dermatophytosis treatment market are concentrating on developing topical treatments such as powders and creams to enhance treatment effectiveness and improve patient satisfaction, addressing the evolving market demands. Powders and creams for dermatophytosis are designed to alleviate itching, absorb moisture, inhibit fungal growth, promote healing, and prevent further infection spread. For instance, in May 2022, Bayer launched Canesten powder and cream, providing relief from various fungal skin infections such as ringworm, jock itch, skin candidiasis, athlete's foot, erythrasma, and fungal nail infections. This product offers five times more relief than ordinary talcum powder, alleviating prickly heat, redness, skin irritation, itching, and fungal infections.

In March 2022, Advent International acquired the pharmaceuticals business of Perrigo Company plc, aiming to expand its healthcare presence and leverage Perrigo's expertise in fungal infection treatment products to drive growth and diversification. Perrigo Company plc, based in Ireland, specializes in providing fungal infection treatment products, including those for ringworm or dermatophytosis.

Major companies operating in the dermatophytosis treatment market are Pfizer Inc., Johnson & Johnson, Bayer AG, Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Astellas Pharma Inc., Valeant Pharmaceuticals International Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Fougera Pharmaceuticals Inc., Galderma S.A., Dr. Reddy's Laboratories Ltd., AmDerma Pharmaceuticals LLC, LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Quinnova Pharmaceuticals Inc., Enzon Pharmaceuticals Inc.

North America was the largest region in the dermatophytosis treatment market in 2024. The regions covered in the dermatophytosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dermatophytosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The dermatophytosis treatment market consists of revenues earned by entities by providing services such as patient education programs, telemedicine consultations, home delivery of medications, dermatology specialist referrals, laboratory testing services, follow-up care, preventive healthcare initiatives. The market value includes the value of related goods sold by the service provider or included within the service offering. The dermatophytosis treatment market also includes sales of medicated shampoos, antifungal creams, prescription lotions, therapeutic powders, herbal remedies, fungal nail treatments, antifungal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dermatophytosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dermatophytosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dermatophytosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatophytosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prescribed; Over The Counter
• 2) By Product Type: Anti-infective; Antifungal; Steroids; Other Product Types
• 3) By Route Of Administration: Oral; Topical
• 4) By End User: Hospital; Clinic; Other End Users
• Subsegments:
• 1) By Prescribed: Oral Antifungal Medications; Topical Antifungal Medications; Combination Therapy
• 2) By Over The Counter: Topical Antifungal Creams; Antifungal Powders; Antifungal Sprays
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Novartis International AG; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dermatophytosis Treatment Market Characteristics

3. Dermatophytosis Treatment Market Trends And Strategies

4. Dermatophytosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Dermatophytosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dermatophytosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dermatophytosis Treatment Market Growth Rate Analysis
• 5.4. Global Dermatophytosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dermatophytosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dermatophytosis Treatment Total Addressable Market (TAM)

6. Dermatophytosis Treatment Market Segmentation

• 6.1. Global Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescribed
• Over The Counter
• 6.2. Global Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-infective
• Antifungal
• Steroids
• Other Product Types
• 6.3. Global Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• 6.4. Global Dermatophytosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinic
• Other End Users
• 6.5. Global Dermatophytosis Treatment Market, Sub-Segmentation Of Prescribed, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antifungal Medications
• Topical Antifungal Medications
• Combination Therapy
• 6.6. Global Dermatophytosis Treatment Market, Sub-Segmentation Of Over The Counter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Antifungal Creams
• Antifungal Powders
• Antifungal Sprays

7. Dermatophytosis Treatment Market Regional And Country Analysis

• 7.1. Global Dermatophytosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dermatophytosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dermatophytosis Treatment Market

• 8.1. Asia-Pacific Dermatophytosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dermatophytosis Treatment Market

• 9.1. China Dermatophytosis Treatment Market Overview
• 9.2. China Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dermatophytosis Treatment Market

• 10.1. India Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dermatophytosis Treatment Market

• 11.1. Japan Dermatophytosis Treatment Market Overview
• 11.2. Japan Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dermatophytosis Treatment Market

• 12.1. Australia Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dermatophytosis Treatment Market

• 13.1. Indonesia Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dermatophytosis Treatment Market

• 14.1. South Korea Dermatophytosis Treatment Market Overview
• 14.2. South Korea Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dermatophytosis Treatment Market

• 15.1. Western Europe Dermatophytosis Treatment Market Overview
• 15.2. Western Europe Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dermatophytosis Treatment Market

• 16.1. UK Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dermatophytosis Treatment Market

• 17.1. Germany Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dermatophytosis Treatment Market

• 18.1. France Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dermatophytosis Treatment Market

• 19.1. Italy Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dermatophytosis Treatment Market

• 20.1. Spain Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dermatophytosis Treatment Market

• 21.1. Eastern Europe Dermatophytosis Treatment Market Overview
• 21.2. Eastern Europe Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dermatophytosis Treatment Market

• 22.1. Russia Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dermatophytosis Treatment Market

• 23.1. North America Dermatophytosis Treatment Market Overview
• 23.2. North America Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dermatophytosis Treatment Market

• 24.1. USA Dermatophytosis Treatment Market Overview
• 24.2. USA Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dermatophytosis Treatment Market

• 25.1. Canada Dermatophytosis Treatment Market Overview
• 25.2. Canada Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dermatophytosis Treatment Market

• 26.1. South America Dermatophytosis Treatment Market Overview
• 26.2. South America Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dermatophytosis Treatment Market

• 27.1. Brazil Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dermatophytosis Treatment Market

• 28.1. Middle East Dermatophytosis Treatment Market Overview
• 28.2. Middle East Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dermatophytosis Treatment Market

• 29.1. Africa Dermatophytosis Treatment Market Overview
• 29.2. Africa Dermatophytosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dermatophytosis Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dermatophytosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dermatophytosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Dermatophytosis Treatment Market Competitive Landscape
• 30.2. Dermatophytosis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Dermatophytosis Treatment Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Merck & Co. Inc.
• 31.4. Mylan N.V.
• 31.5. Astellas Pharma Inc.
• 31.6. Valeant Pharmaceuticals International Inc.
• 31.7. Bausch Health Companies Inc.
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. Perrigo Company plc
• 31.10. Fougera Pharmaceuticals Inc.
• 31.11. Galderma S.A.
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. AmDerma Pharmaceuticals LLC
• 31.14. LEO Pharma A/S
• 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Dermatophytosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dermatophytosis Treatment Market

34. Recent Developments In The Dermatophytosis Treatment Market

35. Dermatophytosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Dermatophytosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dermatophytosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dermatophytosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer